Lumic
Get app

Bandhan Bank Shares Dip on Weak FY27 Projections

This Lumic 'Insights' piece examines the significant drop in Bandhan Bank's stock, which slumped nearly 14%. The decline follows the bank's revised and weaker outlook for FY27, projecting Return on Assets (RoA) between 1.2% and 1.4%. This news has understandably rattled investor confidence in the banking sector. Factors contributing to this outlook include anticipated higher technology spending and increased pressure on deposit costs, which are expected to impact profitability even with stable asset quality. Brokerage firms have responded by trimming their earnings estimates, suggesting that margin recovery for Bandhan Bank might take longer than previously thought. Understanding these dynamics is crucial for navigating the current nervous markets.

Insights

Bandhan Bank Slumps as Weaker FY27 Outlook Shakes investor confidence

about 1 hour ago · Lumic

Bandhan Bank logo with a downward trending stock graph, signifying a share price slump.
Lumic
about 1 hour ago
Bandhan Bank Slumps as Weaker FY27 Outlook Shakes investor confidence
KEY POINTS
Bandhan Bank plunged 14% after lowering FY27 exit RoA guidance to 1.2–1.4% levels.
Higher tech costs and deposit pressure weighed on profits despite stable asset quality.
Brokerages cut earnings estimates as margin recovery is now expected to take longer.
LUMIC INSIGHT
Margins(NIMs) a holy grail for banking stocks.
Business Standard·about 1 hour ago

More in Insights

Nifty 50 index chart showing top gainers and losers on July 22, 2026.
Lumic
about 1 hour ago

Insights

Top Movers and shakers of the day - 22nd July 2026 ( Nifty 50 )

NSE·about 1 hour ago
Indian pharma stocks face uncertainty due to US tariff plans on generic drugs
Lumic
about 3 hours ago

Insights

Indian Pharma Stocks Fall on Trump's Generic Drug Tariff Plan

  • Nifty Pharma declined as Trump's proposed tariff plan weighed on export outlook.
  • Imported generic drugs stay duty-free for two years before phased US tariffs begin.
  • India's major drugmakers face long-term uncertainty in their largest export market.
LUMIC INSIGHT
Pharma shares likely to be under pressure in coming days
Business Standard·about 3 hours ago
Bandhan Bank Stock Falls Post FY27 Outlook | Lumic | Lumic